Cancer risk in patients with inflammatory bowel disease

Gastroenterology Clinics of North America

Volumn 28, Issue 2, 1999, Pages 459-477

  Lewis, J D ^a   Deren, J J ^a   Lichtenstein, G R ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; COLORECTAL CANCER; CROHN DISEASE; ENTERITIS; HUMAN; REVIEW; ULCERATIVE COLITIS;

EID: 0032981043     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70065-0     Document Type: Article

References (101)

1. Beart R.W. Jr J pouch with ileoanal anastomosis Can J Surg 30 1987 361 362
2. C.N. Bernstein F. Shanahan W.M. Weinstein Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis Lancet 343 1994 71 74
3. M.O. Blackstone R.H. Riddell B.H. Rogers Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomy Gastroenterology 80 1981 366 374
4. Y. Bouhnik M. Lemann J.Y. Mary Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine Lancet 347 1996 215 219
5. T.A. Brentnall D.A. Crispin P.S. Rabinovitch Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis Gastroenterology 107 1994 369 378
6. T.A. Brentnall R.C. Haggitt P.S. Rabinovitch Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis Gastroenterology 110 1996 331 338
7. U. Broome G. Lindberg R. Lofberg Primary sclerosing cholangitis in ulcerative colitis—a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology 102 1992 1877 1880
8. U. Broome R. Lofberg K. Lundqvist Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis Dis Colon Rectum 38 1995 1301 1305
9. U. Broome R. Lofberg B. Veress Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential Hepatology 22 1995 1404 1408
10. O. Brostrom R. Lofberg B. Nordenvall The risk of colorectal cancer in ulcerative colitis: An epidemiologic study Scand J Gastroenterol 22 1987 1193 1199
11. O. Brostrom R. Lofberg A. Ost Cancer surveillance of patients with longstanding ulcerative colitis: A clinical, endoscopical, and histological study Gut 27 1986 1408 1413
12. G.C. Burmer D.A. Crispin V.R. Kolli Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis Cancer Commun 3 1991 167 172
13. G.C. Burmer D.S. Levine B.G. Kulander c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma Gastroenterology 99 1990 416 420
14. J. Chen C. Compton E. Cheng c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis Gastroenterology 102 1992 1983 1987
15. P.M. Choi M.P. Zelig Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: Implications for carcinogenesis and prevention Gut 35 1994 950 954
16. W.R. Connell M.A. Kamm M. Dickson Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease Lancet 343 1994 1249 1252
17. W.R. Connell J.E. Lennard-Jones C.B. Williams Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis Gastroenterology 107 1994 934 944
18. G.J. Devroede W.F. Taylor W.G. Sauer Cancer risk and life expectancy of children with ulcerative colitis N Engl J Med 285 1971 17 21
19. G. D'Haens B.A. Lashner S.B. Hanauer Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis Am J Gastroenterol 88 1993 1174 1178
20. A. Ekbom C. Helmick M. Zack Extracolonic malignancies in inflammatory bowel disease Cancer 67 1991 2015 2019
21. A. Ekbom C. Helmick M. Zack Increased risk of large-bowel cancer in Crohn's disease with colonic involvement Lancet 336 1990 357 359
22. A. Ekbom C. Helmick M. Zack Ulcerative colitis and colorectal cancer: A population-based study N Engl J Med 323 1990 1228 1233
23. R. Farrell P. Kileen N. Mahmud Increased risk of non-Hodgkin's lymphoma with immunomodulatory therapy in inflammatory bowel disease Gastroenterology 112 1997 A969
24. E.R. Fearon B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
25. J.F. Fielding P. Prior J.A. Waterhouse Malignancy in Crohn's disease Scand J Gastroenterol 7 1972 3 7
26. Z. Fireman A. Grossman P. Lilos Intestinal cancer in patients with Crohn's disease: A population study in central Israel Scand J Gastroenterol 24 1989 346 350
27. A. Gelb R. Zalusky The use of azathioprine and 6-mercaptopurine (6-MP) as immunosuppressive therapy in inflammatory bowel disease and its role in the etiology of lymphocytic lymphoma [letter] Am J Gastroenterol 78 1983 316
28. J. George D.H. Present R. Pou The long-term outcome of ulcerative colitis treated with 6-mercaptopurine Am J Gastroenterol 91 1996 1711 1714
29. T. Gilat Z. Fireman A. Grossman Colorectal cancer in patients with ulcerative colitis: A population study in central Israel Gastroenterology 94 1988 870 877
30. C.D. Gillen H.A. Andrews P. Prior Crohn's disease and colorectal cancer Gut 35 1994 651 655
31. C.D. Gillen R.S. Walmsley P. Prior Ulcerative colitis and Crohn's disease: A comparison of the colorectal cancer risk in extensive colitis Gut 35 1994 1590 1592
32. E. Giovannucci K.M. Egan D.J. Hunter Aspirin and the risk of colorectal cancer in women N Engl J Med 333 1995 609 614
33. E.R. Greenberg J.A. Baron Freeman D.H. Jr Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group J Natl Cancer Inst 85 1993 912 916
34. A.J. Greenstein R. Gennuso D.B. Sachar Extraintestinal cancers in inflammatory bowel disease Cancer 56 1985 2914 2921
35. A.J. Greenstein D.B. Sachar H. Smith A comparison of cancer risk in Crohn's disease and ulcerative colitis Cancer 48 1981 2742 2745
36. K. Gullberg D. Stahlberg L. Liljeqvist Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis Gastroenterology 112 1997 1487 1492
37. A.K. Gurbuz F.M. Giardiello T.M. Bayless Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis Dis Colon Rectum 38 1995 37 41
38. S. Gyde Screening for colorectal cancer in ulcerative colitis: Dubious benefits and high costs Gut 31 1990 1089 1092
39. S. Gyde P. Prior M.J. Dew Mortality in ulcerative colitis Gastroenterology 83 1 Pt 1 1982 36 43
40. S.N. Gyde P. Prior R.N. Allan Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centres Gut 29 1988 206 217
41. S.N. Gyde P. Prior J.C. Macartney Malignancy in Crohn's disease Gut 21 1980 1024 1029
42. C.H. Halsted G. Gandhi T. Tamura Sulfasalazine inhibits the absorption of folates in ulcerative colitis N Engl J Med 305 1981 1513 1517
43. S.R. Hamilton Colorectal carcinoma in patients with Crohn's disease Gastroenterology 89 1985 398 407
44. C. Hendriksen S. Kreiner V. Binder Long term prognosis in ulcerative colitis—based on results from a regional patient group from the county of Copenhagen Gut 26 1985 158 163
45. H.W. Jones J. Grogono A.M. Hoare Surveillance in ulcerative colitis: Burdens and benefit Gut 29 1988 325 331
46. I. Katzka R.S. Brody E. Morris Assessment of colorectal cancer risk in patients with ulcerative colitis: Experience from a private practice Gastroenterology 85 1983 22 29
47. L.J. Kinlen Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment Am J Med 78 1985 44 49
48. A. Kornbluth D.B. Sachar Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee Am J Gastroenterol 92 1997 204 211
49. N. Kvist O. Jacobsen P. Norgaard Malignancy in Crohn's disease Scand J Gastroenterol 21 1986 82 86
50. L. Larvol J.C. Soule Le Tourneau A. Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease [letter] N Engl J Med 331 1994 883 884
51. B. Lashner K. Shetty L. Rybicki Risk factors for cancer or dysplasia in ulcerative colitis with primary sclerosing cholangitis Gastroenterology 114 1998 A1018
52. B.A. Lashner Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis J Cancer Res Clin Oncol 119 1993 549 554
53. B.A. Lashner K.S. Provencher D.L. Seidner The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis Gastroenterology 112 1997 29 32
54. B.A. Lashner M.D. Silverstein S.B. Hanauer Hazard rates for dysplasia and cancer in ulcerative colitis: Results from a surveillance program Dig Dis Sci 34 1989 1536 1541
55. J.E. Lennard-Jones D.M. Melville B.C. Morson Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years Gut 31 1990 800 806
56. J.E. Lennard-Jones B.C. Morson J.K. Ritchie Cancer surveillance in ulcerative colitis: Experience over 15 years Lancet 2 1983 149 152
57. R. Lofberg L. Liljeqvist K. Lindquist Dysplasia and DNA aneuploidy in a pelvic pouch: Report of a case Dis Colon Rectum 34 1991 280 284
58. E. Loftus W. Sandborn W. Tremaine Risk of lymphoma in inflammatory bowel disease: A population-based estimate Gastroenterology 114 1998 A1024
59. Loftus E.V. Jr W.J. Sandborn W.J. Tremaine Risk of colorectal neoplasia in patients with primary sclerosing cholangitis Gastroenterology 110 1996 432 440
60. K. Lundqvist U. Broome Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: A case control study Dis Colon Rectum 40 1997 451 456
61. I.P.M. MacDougall The cancer risk in ulcerative colitis Lancet 2 1964 655 658
62. A.P. Manning O.R. Bulgim M.F. Dixon Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease Gut 28 1987 1489 1494
63. P.W. Marcello P.L. Roberts Schoetz D.J. Jr Long-term results of the ileoanal pouch procedure Arch Surg 128 1993 500 504
64. P. Marchesa B.A. Lashner I.C. Lavery The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis Am J Gastroenterol 92 1997 1285 1288
65. G.I. Meling O.P. Clausen A. Bergan Flow cytometric DNA ploidy pattern in dysplastic mucosa, and in primary and metastatic carcinomas in patients with longstanding ulcerative colitis Br J Cancer 64 1991 339 344
66. Mir Madjlessi S.H. R.G. Farmer J.K. Weick Inflammatory bowel disease and leukemia: A report of seven cases of leukemia in ulcerative colitis and Crohn's disease and review of the literature Dig Dis Sci 31 1986 1025 1031
67. S.H. Mir-Madjlessi R.G. Farmer K.A. Easley Colorectal and extracolonic malignancy in ulcerative colitis Cancer 58 1986 1569 1574
68. P. Munkholm E. Langholz M. Davidsen Intestinal cancer risk and mortality in patients with Crohn's disease Gastroenterology 105 1993 1716 1723
69. J.E. Muscat S.D. Stellman E.L. Wynder Nonsteroidal antiinflammatory drugs and colorectal cancer Cancer 74 1994 1847 1854
70. K.W. Nuako D.A. Ahlquist W.J. Sandborn Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: A case-control study Cancer 82 1998 822 826
71. F.W. Nugent R.C. Haggitt P.A. Gilpin Cancer surveillance in ulcerative colitis Gastroenterology 100 5 Pt 1 1991 1241 1248
72. G. Opelz R. Henderson Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients Lancet 342 1993 1514 1516
73. M.A. Peppercom 6-Mercaptopurine for the management of ulcerative colitis: A concept whose time has come [edit; comment] Am J Gastroenterol 91 1996 1689 1690
74. P.G. Persson P. Karlen O. Bernell Crohn's disease and cancer: A population-based cohort study Gastroenterology 107 1994 1675 1679
75. M. Pescatori C. Mattana M. Castagneto Clinical and functional results after restorative proctocolectomy Br J Surg 75 1988 321 324
76. D. Pinczowski A. Ekbom J. Baron Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study Gastroenterology 107 1994 117 120
77. D.K. Podolsky Inflammatory bowel disease (2) N Engl J Med 325 1991 1008 1016
78. D.H. Present S.J. Meltzer M.P. Krumholz 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity Ann Intern Med 111 1989 641 649
79. R.H. Riddell H. Goldman D.F. Ransohoff Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications Hum Pathol 14 1983 931 968
80. J.C. Rodriguez-Sanjuan M.G. Polavieja A. Naranjo Adenocarcinoma in an ileal pouch for ulcerative colitis [letter] Dis Colon Rectum 38 1995 779 780
81. J. Romanos D.N. Samarasekera J.F. Stebbing Outcome of 200 restorative proctocolectomy operations: The John Radcliffe Hospital experience Br J Surg 84 1997 814 818
82. E. Rosenstock R.G. Farmer R. Petras Surveillance for colonic carcinoma in ulcerative colitis Gastroenterology 89 1985 1342 1346
83. P. Rozen M. Baratz F. Fefer Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis Gastroenterology 108 1995 1361 1370
84. C.E. Rubin R.C. Haggitt G.C. Burmer DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis Gastroenterology 103 1992 1611 1620
85. W.J. Sandborn A review of immune modifier therapy for inflammatory bowel disease: Azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate Am J Gastroenterol 91 1996 423 433
86. R. Sequens Cancer in the anal canal (transitional zone) after restorative proctocolectomy with stapled ileal pouch-anal anastomosis Int J Colorectal Dis 12 1997 254 255
87. A.J. Silman J. Petrie B. Hazleman Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: A 20 year follow up study Ann Rheum Dis 47 1988 988 992
88. R.F. Souza J. Lei J. Yin A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms Gastroenterology 112 1997 40 45
89. H. Stern S. Walfisch B. Mullen Cancer in an ileoanal reservoir: A new late complication? Gut 31 1990 473 475
90. A. Sugita D.B. Sachar C. Bodian Colorectal cancer in ulcerative colitis: Influence of anatomical extent and age at onset on colitis-cancer interval Gut 32 1991 167 169
91. O. Suh C. Mettlin N.J. Petrelli Aspirin use, cancer, and polyps of the large bowel Cancer 72 1993 1171 1177
92. H. Suzuki N. Harpaz L. Tarmin Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers Cancer Res 54 1994 4841 4844
93. C.M. Swinson J. Perry M. Lumb Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis Gut 22 1981 456 461
94. L. Tarmin J. Yin N. Harpaz Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms Cancer Res 55 1995 2035 2038
95. M.J. Thun M.M. Namboodiri Heath C.W. Jr Aspirin use and reduced risk of fatal colon cancer N Engl J Med 325 1991 1593 1596
96. D.D. Weedon R.G. Shorter D.M. Ilstrup Crohn's disease and cancer N Engl J Med 289 1973 1099 1103
97. A.H. Wilkinson J.L. Smith L.G. Hunsicker Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone Transplantation 47 1989 293 296
98. R.F. Willenbucher S.J. Zelman L.D. Ferrell Chromosomal alterations in ulcerative colitis-related neoplastic progression Gastroenterology 113 1997 791 801
99. A.J. Woolrich M.D. DaSilva B.I. Korelitz Surveillance in the routine management of ulcerative colitis: The predictive value of low-grade dysplasia Gastroenterology 103 1992 431 438
100. J. Yin N. Harpaz Y. Tong p53 Point mutations in dysplastic and cancerous ulcerative colitis lesions Gastroenterology 104 1993 1633 1639
101. Y. Ziv V.W. Fazio M.T. Sirimarco Incidence, risk factors, and treatment of dysplasia in the anal transitional zone after ileal pouch-anal anastomosis Dis Colon Rectum 37 1994 1281 1285